Trial intelligence / Profile preview

Formulations containing nisin and/or dextranase enzyme against cariogenic and periodontopathic microorganisms

TCTR20190927005Phase 1Completed

Sponsor
Faculty of Pharmacy
Start
Jun 2019
Modality
Recombinant Proteins and Enzymes, Peptides
Countries
1
01

Overview

Phase 1 trial of nisin in carious lesion and gingival disease, sponsored by Faculty of Pharmacy. Started Jun 2019; status: completed.

02

Drugs

nisin
03

Conditions

carious lesiongingival disease

Beyond the preview

Go deeper on TCTR20190927005.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20190927005.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call